Elsevier

Neurobiology of Aging

Volume 16, Issue 3, May–June 1995, Pages 285-298
Neurobiology of Aging

Correlations of synaptic and pathological markers with cognition of the elderly

https://doi.org/10.1016/0197-4580(95)00013-5Get rights and content

Abstract

It has been suggested that the physical basis for dementia is structural or functional loss of synapses. To confirm this finding, we performed an enzyme-linked immunoassay (ELISA) with a monoclonal antibody (EP 10) to a synaptophysin-like protein in brain samples from 45 prospectively studied elderly subjects with an average age of 83.3 ± 10.1 years. We compared the synaptic marker to immunoreactivity with a newly developed PHF antibody (TG3). The cases were selected on the basis of availability of frozen tissue, and included subjects ranging from clinically normal to end-stage dementia. As an initial assessment, we determined Pearson product moment correlations for two clinical measures—the Blessed test of information, concentration, and memory (BICM) and the Fuld object Memory Evaluation (FOME)—with ELISA data and with traditional pathologic markers. We found strong correlations (p < 0.01-0.001) for BICM with brain weight, neuronal loss in the basal nucleus of Meynert (nbM), counts of senile plaques (SP) in the neocortex and hippocampus, and neurofibrillary tangles (NFT) in all areas except the parahippocampal cortex. Except in the occipital lobe, where paired helical filament changes are relatively uncommon, TG3-immunoreactivity also correlated strongly with BICM. Weak correlations (p < 0.05) were found for BICM with EP10-immunoreactivity in only the temporal and parietal lobes. Only the pathologic variables showed any significant correlations with FOME. Because inclusion of normal subjects with few or no pathologic lesions could have been driving the strong correlations with pathologic markers, we limited the analysis to those subjects with dementia (BICM; 8). After making this correction, EP10-immunoreactivity in all cortical areas and the hippocampus correlated better (p < 0.05-0.01) with BICM but not FOME. The present univariate analysis suggests that synaptic markers may not be the best structural correlate of dementia and that markers indicative of cytoskeletal changes, e.g., SP, NFT and PHF protein accumulation, may be better correlates of dementia in the elderly.

References (47)

  • C.F. Lippa et al.

    Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses

    Neurobiol. Aging

    (1992)
  • E. Masliah et al.

    Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease

    Neurosci. Lett.

    (1989)
  • M.M. Paula-Barbosa et al.

    Dendritic degeneration and regrowth in the cerebral cortex of patients with Alzheimer's disease

    J. Neurol. Sci.

    (1980)
  • S.W. Scheff et al.

    Quantitative assessment of cortical synaptic density in Alzheimer's disease

    Neurobiol. Aging

    (1990)
  • B.E. Tomlinson et al.

    Observations on the brains of nondemented old people

    J. Neurol. Sci.

    (1968)
  • G.K. Wilcock et al.

    Plaques, tangles and dementia: A quantitative study

    J. Neurol. Sci.

    (1982)
  • I.M. Adams

    Structural plasticity of synapses in Alzheimer's disease

    Mol. Neurobiol.

    (1991)
  • M.F. Alford et al.

    A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain

    J. Histochem. Cytochem.

    (1994)
  • M.K. Aronson et al.

    Women, myocardial infarction, and dementia in the very old

    Neurology

    (1990)
  • G. Blessed et al.

    The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects

    Br. J. Psychiatry

    (1968)
  • H. Crystal et al.

    Clinicopathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease

    Neurology

    (1988)
  • H.A. Crystal et al.

    Pathological markers associated with normal aging and dementia in the elderly

    Ann. Neurol.

    (1993)
  • P. Davies et al.

    TG3: A better antibody than Alz-50 for the visualization of Alzheimer-type neuronal pathology

    Soc. Neurosci. Abstr.

    (1993)
  • Cited by (375)

    • Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology

      2021, Progress in Neurobiology
      Citation Excerpt :

      The Cholinergic Hypothesis (Appel, 1981) has been supported by several evidences indicating that cholinergic transmission is affected in early AD. Indeed, loss of cholinergic neurons in the nucleus basalis of Meynert, decrease of choline acetyltransferase (ChAT) activity and reduction of nicotinic receptors (nAChRs) have been highly correlated with dementia and its progression (Burghaus et al., 2000; Dickson et al., 1995; Engidawork et al., 2001; Kuhn et al., 2015; Mufson et al., 2007; Strada et al., 1992; Whitehouse et al., 1981). On the other hand, the Aβ Hypothesis (Hardy and Allsop, 1991) posits that the increase and accumulation of Aβ represent the primum movens in AD pathophysiology, responsible of synaptic dysfunction triggering downstream events leading to dementia [reviewed in (Gulisano et al., 2018a)].

    View all citing articles on Scopus
    View full text